Treatment with Ivermectin Increases the Population of Bifidobacterium in the Gut

Hazan et al., ACG 2023, Oct 2023
Ivermectin for COVID-19
4th treatment shown to reduce risk in August 2020, now with p < 0.00000000001 from 106 studies, recognized in 24 countries.
Lower risk for mortality, ventilation, ICU, hospitalization, recovery, cases, and viral clearance.
No treatment is 100% effective. Protocols combine treatments.
6,300+ studies for 210+ treatments. c19early.org
Meta Analysis
Analysis of the effect of ivermectin on the gut microbiome, showing a significant increase in Bifidobacterium.
Bifidobacterium plays a key role in the immune system, for example enhancing antibody production, facilitating the induction of regulatory T cells, modulating the immune response of macrophages, dendritic cells, and T cells, maintaining gut barrier integrity, and inhibiting harmful microbes.
Increased Bifidobacterium is associated with lower COVID-19 severity1.
Important missing comments or errors? Let us know.
Study covers probiotics and ivermectin.
Hazan et al., 22 Oct 2023, preprint, 4 authors.
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit    
Post
Share
@CovidAnalysis
FAQ
Public domain CC0 1.0